-
August 23: The Week in Cancer NewsRecommendations say that a broader group of women should be considered for BRCA mutation testing, and the U.S. Food and Drug Administration issues a proposal to require that cigarettes come with graphic warnings.
by Kate Yandell
-
August 16: The Week in Cancer NewsA radiation oncologist draws on her personal experience as she researches financial toxicity, and the U.S. Food and Drug Administration issues a third tissue-agnostic approval.
by Kate Yandell
-
August 9: The Week in Cancer NewsA liquid biopsy test is effective in detecting a cancer biomarker, Medicare opts to cover CAR-T cell therapies, and an e-cigarette maker spends millions to defeat a ban on sales in San Francisco.
by Kevin McLaughlin
-
August 2: The Week in Cancer NewsThe U.S. Food and Drug Administration for the first time approves an immune checkpoint inhibitor for treatment of esophageal cancer, and a two-drug combination shows promise for treating chronic lymphocytic leukemia.
by Kate Yandell
-
July 26: The Week in Cancer NewsThe U.S. Food and Drug Administration requests a recall of textured breast implants, and a study indicates BRCA2 mutations are associated with non-Hodgkin lymphoma.
by Kate Yandell
-
July 19: The Week in Cancer NewsA study sheds light on the effects of hurricanes on cancer patients receiving radiation therapy, and the Biden Cancer Initiative suspends operations.
by Kate Yandell and Bradley Jones
-
July 12: The Week in Cancer NewsA combination of three targeted therapies can lengthen survival for some patients with metastatic colorectal cancer, and patients receiving stem cell transplants can benefit from shingles vaccines.
by Kate Yandell
-
June 28: The Week in Cancer NewsA study indicates that many African Americans who could benefit from lung cancer screening are not eligible, and an oncologist writes about his experiences with medical aid in dying.
by Kate Yandell
-
June 21: The Week in Cancer NewsA study shows that more than a third of U.S. cancer survivors experience chronic pain, and the U.S. Food and Drug Administration approves another immunotherapy for treatment of small cell lung cancer.
by Kate Yandell
-
June 14: The Week in Cancer NewsA physician writes about the long-term effects of her treatment for Hodgkin lymphoma in the 1960s, and the U.S. Food and Drug Administration approves an immunotherapy drug as an initial treatment for metastatic head and neck cancer.
by Kate Yandell
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
